The correlation between pretreatment CD103+ T cells (CD4 P1, CD8 P7, and P8) and the presence or absence of MPR defined as ≥90% tumor regression is shown in Fig. 3 where data is presented stratified by treatment arm as well as for all patients regardless of treatment assignment. Here, CD4 is linked to neoplasm.